Skip to Content

Join the 'Vivitrol' group to help and get support from people like you.

Vivitrol News

5 Diet Drugs: Which Ones Work?

Posted 14 Jun 2016 by Drugs.com

TUESDAY, June 14, 2016 – Any of the prescription weight-loss drugs on the market can help obese people shed pounds, although some seem more effective than others, a new study finds. Currently, five drugs are approved in the United States for managing obesity. But little has been known about how they stack up against one another, said Dr. Siddharth Singh, the lead researcher on the new study. The findings – based on more than 29,000 people in total – show all five drugs can work. But people on certain drugs tended to be more successful, at least over one year. Specifically, people using Qsymia (phentermine-topiramate) or Victoza (liraglutide) had the highest odds of shedding at least 5 percent of their initial weight. Those taking Xenical (orlistat) had the lowest odds. However, there is no single drug that's "best" for everyone, stressed Singh, an assistant clinical professor at the ... Read more

Related support groups: Obesity, Wellbutrin, Phentermine, Weight Loss, Bupropion, Contrave, Belviq, Wellbutrin XL, Victoza, Adipex-P, Wellbutrin SR, Qsymia, Naltrexone, Xenical, Vivitrol, Orlistat, Saxenda, Alli, Zyban, Liraglutide

3 in 10 Americans Have Drinking Problem at Some Point in Their Lives

Posted 3 Jun 2015 by Drugs.com

WEDNESDAY, June 3, 2015 – Nearly 30 percent of Americans have a problem with alcohol at some point in their lives, ranging from binge drinking to full-blown alcoholism, but less than 20 percent are ever treated, a new study found. Alcohol use disorders are among the most common mental health problems worldwide and result in disability, illness and death, researchers from the U.S. National Institute on Alcohol Abuse and Alcoholism (NIAAA) said. "The problem of alcohol abuse is bigger than people thought," said NIAAA Director George Koob. "Alcohol disorders cost the United States $224 billion a year. "Seventy percent of Americans drink and most don't have a problem, but there is a significant group that do have a problem," he added. One of the biggest concerns, Koob said, is that less than 20 percent of those who have a drinking problem get help. Koob thinks people avoid treatment for a ... Read more

Related support groups: Contrave, Naltrexone, Alcohol Dependence, Vivitrol, Alcohol Withdrawal, Alcoholism, Campral, Hangover, Embeda, Acamprosate, Revia, Bupropion/naltrexone, Campral EC, Acute Alcohol Intoxication, Depade, Morphine/naltrexone

Drug May Help Women Who Quit Smoking Avoid Weight Gain

Posted 27 Dec 2012 by Drugs.com

THURSDAY, Dec. 27 – Taking a pill called naltrexone (ReVia) when they stop smoking could help women keep dreaded weight gain at bay, according to new research. Researchers analyzed two earlier studies that compared the quit rates and weight gain among heavy smokers who received either naltrexone – a drug used to treat addiction – or an inactive placebo, along with a nicotine patch and weekly counseling while trying to quit smoking. Although the groups taking naltrexone had higher quit rates at the end of four- and six-week treatment courses, participants who took the drug were no more likely to remain abstinent after 12 months. But women who took naltrexone gained significantly less weight six and 12 months after they quit smoking than women who received the placebo, according to the study, published in the December issue of Biological Psychiatry. However, this difference was not ... Read more

Related support groups: Smoking Cessation, Naltrexone, Vivitrol, Revia, Depade

FDA Approves Vivitrol to Treat Opioid-dependent Patients

Posted 13 Oct 2010 by Drugs.com

ROCKVILLE, Md., Oct. 12, 2010--The U.S. Food and Drug Administration today approved Vivitrol to treat and prevent relapse after patients with opioid dependence have undergone detoxification treatment. Vivitrol is an extended-release formulation of naltrexone administered by intramuscular injection once a month. Naltrexone works to block opioid receptors in the brain. It blocks the effects of drugs like morphine, heroin, and other opioids. It was approved to treat alcohol dependence in 2006. "Addiction is a serious problem in this country, and can have devastating effects on individuals who are drug-dependent, and on their family members and society," said Janet Woodcock, M.D., director of FDA's Center for Drug Evaluation and Research. "This drug approval represents a significant advancement in addiction treatment." The safety and efficacy of Vivitrol were studied for six months, ... Read more

Related support groups: Opiate Dependence, Naltrexone, Vivitrol

Combination Treatment May Help Depressed Alcoholics

Posted 15 Mar 2010 by Drugs.com

MONDAY, March 15 – Combined treatment with the antidepressant Zoloft (sertraline) and the alcoholism drug naltrexone improves the likelihood that people with both major depression and alcohol dependence will be able to stop drinking, U.S. researchers report. Their 14-week study of 170 patients found that 54 percent of those who received the combined treatment were able to stop drinking, compared with 21 to 28 percent for patients who received a placebo, Zoloft only, or naltrexone only. The patients who received the combined treatment also went for a longer period of time before they started drinking again – 61 days compared with 15 days for patients in the other groups. The findings may prove an important advance in the treatment of patients with alcohol dependence and depression, said the University of Pennsylvania researchers. "When depression and alcohol dependence occur together, ... Read more

Related support groups: Zoloft, Naltrexone, Alcohol Dependence, Vivitrol, Alcoholism, Revia

Addiction Meds May Help Gamblers

Posted 10 Dec 2009 by Drugs.com

THURSDAY, Dec. 10 – Drugs used to treat substance addictions could prove effective in treating pathological gambling, U.S. researchers say. They tested medications designed to decrease urges and increase inhibitions in two groups of male and female pathological gamblers: those driven by urge (they gamble when the desire becomes too strong to control) and those who don't have normal inhibition of impulsive behaviors (they're unable to control the desire to gamble even when the urges are minimal or nonexistent). The first group – those driven by urge – responded well to medications that block the brain opioid system (such as naltrexone) or certain receptors for the neurotransmitter glutamate (such as memantine). Gamblers with a family history of the problem responded especially well to the opioid blocker, the study found. The second group – those unable to control any impulse to ... Read more

Related support groups: Naltrexone, Namenda, Vivitrol, Memantine, Revia

FDA Medwatch Alert: Vivitrol (naltrexone)

Posted 12 Aug 2008 by Drugs.com

[Posted 08/12/2008] FDA informed healthcare professionals of the risk of adverse injection site reactions in patients receiving naltrexone. Naltrexone is indicated for the treatment of alcohol dependence in patients who are able to abstain from alcohol in an outpatient setting prior to initiation of treatment. Naltrexone is administered as an intramuscular gluteal injection and should not be administered intravenously, subcutaneously, or inadvertently into fatty tissue. Physicians should instruct patients to monitor the injection site and contact them if they develop pain, swelling, tenderness, induration, bruising, pruritus, or redness at the injection site that does not improve or worsens within two weeks. Physicians should promptly refer patients with worsening injection site reactions to a surgeon. Read the FDA recommendations for healthcare professionals to consider regarding the ... Read more

Related support groups: Vivitrol

Ask a Question

Further Information

Related Condition Support Groups

Alcohol Dependence, Opiate Dependence

Vivitrol Patient Information at Drugs.com